Marysol García Patiño graduated with honours as a Biotechnology Engineer from Tecnológico de Monterrey, in Monterrey, Mexico. Then, she obtained her masters degree on Biotechnology at the same institution. She was part of Dr. Sergio Serna-Saldivar’s research group, and during that time she focused on researching the anti-inflammatory effects of saponins and flavonoids extracted from black bean (Phaseolus vulgaris L).
Marysol is now a PhD candidate on Pharmaceutical Sciences at the University of British Columbia, in Vancouver, Canada. She works in the research group of Molecular and Cellular Pharmacology, and is part of Dr. Kathleen MacLeod lab. The objective of her thesis is to know the role of Rho kinase 2 in the development of myocardial ischemia-reperfusion injury. She is focused on evaluating the effects of this phenomenon under normal physiological conditions and during hyperglycemia. Since 2012, she has a scholarship from CONACyT. Marysol has collaborated in the development of 2 published papers, and 2 publications in progress.